Search Results
Looking for product information? Go to the HPRA website
Showing 7 from 7 results
Our ESG Progress: Four Employee Perspectives
Each year, we issue a report highlighting our Environmental, Social and Governance (ESG) progress. This report reflects our efforts to improve the health of patients and communities and promote transparency and accountability across our business.
How We’re Helping Battle a Global Epidemic: Non Communicable Diseases (NCDs)
Around the world, NCDs are an ever-growing threat—and the burden of dealing with them falls disproportionately on low-income countries. Learn more.
Smart tech devices provide a sense of community for people with MS
Smart watches and smart scales aren’t just useful for counting steps or cutting calories. If you’re living with multiple sclerosis (MS), these devices can help build a community with others in a similar position.
Get them dirty: children’s play campaign encourages exploration of the natural world
The Play More campaign focuses on the idea that modern children need to get away from their computer screens and spend more time in the woods or the playground. Learn more
The bottom line on generics in Ireland
The use of pharmaceutical generics can increase cost-effectiveness and efficiency in health care provision and spending. Learn more.
Generic Medicines in Ireland
In 2013, Ireland introduced compulsory generic medicines substitution into the country and now, five years on, we’re seeing the real economic impact of that initiative. Learn more
Fighting back against counterfeit medicines
Teva supports the implementation, in Ireland, of the EU Directive on Falsified Medicines (2011/62/EU) to combat the issue of counterfeit medicine entering the proper supply chain.
Date of preparation: October 2023
Reference: COB-IE-NP-00016 (V8.0)